Showing 101 - 120 results of 316 for search '"Eye disease"', query time: 0.06s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107

    Therapeutic applications of artemisinin in ophthalmic diseases by Hao Sun, Ping Zhao, Lianghui Zhao, Zhizhong Zhao, Haoyu Chen, Cong Ren, Bin Guo

    Published 2025-01-01
    “…Recently, studies confirmed that artemisinin plays therapeutic roles in eye diseases through regulation of signaling pathways, such asNrf2/HO-1/Keap1, TLR/MyD88/NF-κb, PI3K/AKT/mTOR, and FASN/Kmal-mTOR/SREBP1, and biological factors, such as protein kinase B, AMP-activated protein kinase, tumor necrosis factor alpha, nod-like receptor protein 3, vascular endothelial growth factor, malonyl-coenzyme A and cytochrome C. …”
    Get full text
    Article
  8. 108
  9. 109
  10. 110

    A Ligation of the Lacrimal Excretory Duct in Mouse Induces Lacrimal Gland Inflammation with Proliferative Cells by Ying Liu, Masatoshi Hirayama, Tetsuya Kawakita, Kazuo Tsubota

    Published 2017-01-01
    “…The dysfunction of the lacrimal glands causes dry eye disease due to a reduction in tear volume. The dry eye disease is becoming a popular public disease, for the number of patients is increasing, who have subjective symptom and loss of vision, which affect the quality of life. …”
    Get full text
    Article
  11. 111

    The Correlation between Matrix Metalloproteinase-9 Point-of-Care Immunoassay, Tear Film Osmolarity, and Ocular Surface Parameters by Min-Ji Kang, Hyun Seung Kim, Man Soo Kim, Eun Chul Kim

    Published 2022-01-01
    “…Background. Dry eye disease is a multifactorial disease that is difficult to diagnose due to multiple causative factors. …”
    Get full text
    Article
  12. 112

    Insights into parental perspectives: Children's eye care in Saudi Arabia by Sokinah N. Al Musalami, Reem J. Al Qasim, Bayan S. Alshuhayb, Abdulaziz I. Al-Somali

    Published 2025-01-01
    “…However, parents from the central region, healthcare workers, and those having a child with an eye disease were more likely to have their children's eyes checked regularly. …”
    Get full text
    Article
  13. 113

    Effective low-cost pediatric vision screening by naive nonophthalmic examiners using the ‘Arclight’ device by Rujuta Gore, Jenny N Wang, Christopher D Yang, Miranda An, Stephen C Hunter, Kourosh Shahraki, Andrew Blaikie, Donny W Suh

    Published 2025-01-01
    “…Purpose: To explore whether a low-cost ophthalmoscope (Arclight) can be used by naive nonophthalmic examiners to effectively screen for pediatric eye disease. Methods: Fifty-four children (108 eyes) were examined by five medical students using an Arclight. …”
    Get full text
    Article
  14. 114

    Correlation of nailfold capillaroscopic changes using handheld dermatoscope with varying grades and severity of diabetic retinopathy in patients with type 2 diabetes mellitus: A pi... by Rohit Raina, Neha Chhabra, Shruti Barnwal, Shivani Vasisht, Naveen Kumar Kansal, Ravi Kant

    Published 2025-01-01
    “…Patients with avascular areas/3 mm, tortuous capillaries/3 mm, and abrogated/bushy capillaries/3 mm were significantly higher (P < 0.05) in advanced diabetic eye disease and diabetic macular edema (DME). All patients with advanced diabetic eye disease and DME had any finger involved excluding the thumb with abnormal NFC score which indicates the highest correlation between the severity of retinopathy and involvement of microvascular abnormality in the proximal nailfold. …”
    Get full text
    Article
  15. 115

    Real-World Treatment Outcomes of an Artificial Tear Containing Arabinogalactan, Hyaluronic Acid and Trehalose Among Subjects with Dry Eye by Bedei A, Rocha Cabrera P, Oliveira L, Castellini L, De Grazia G, Remiddi S

    Published 2025-01-01
    “…Additionally, 61% of the patients experienced 1– 2 hours of comfort following instillation.Conclusion: This real-life post-marketing study demonstrated clinical improvement of signs and symptoms in patients with dry eye disease using a new artificial tear medical device based on arabinogalactan, hyaluronic acid, and trehalose.Keywords: dry eye, real-world study, arabinogalactan, hyaluronic acid, trehalose, post-marketing study…”
    Get full text
    Article
  16. 116
  17. 117

    In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients by Manuela Lanzini, Claudia Curcio, Rossella Annamaria Colabelli-Gisoldi, Alessandra Mastropasqua, Roberta Calienno, Luca Agnifili, Mario Nubile, Leonardo Mastropasqua

    Published 2015-01-01
    “…The aim of this study is to investigate in vivo and ex vivo ocular surface alterations induced by dry eye disease and modification after osmoprotective therapy. …”
    Get full text
    Article
  18. 118

    Central Serous Chorioretinopathy Associated with Corticosteroid Use in a Patient with Leber Hereditary Optic Neuropathy: A Case Report by Lepsa Zoric, Aleksandra Petrovic, Vladimir Milutinovic

    Published 2024-12-01
    “…The decline in vision developed gradually over 20 days, prior to the patient’s referral to the UKCS Eye Disease Clinic for further examination and treatment, and was not accompanied by pain during eye movements. …”
    Get full text
    Article
  19. 119

    Cytokines in Thyroid-Associated Ophthalmopathy by Pengbo Zhang, Huang Zhu

    Published 2022-01-01
    “…Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves’ orbitopathy (GO), is a complex autoimmune condition causing visual impairment, disfigurement, and harm to patients’ physical and mental health. …”
    Get full text
    Article
  20. 120

    Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial by Yue Zhao, Guang Yang, Yun-Qiong Lu, Mei-Yan Li, Jue Hong, Yan-Ting Yang, Xue-Jun Wang, Xie-He Kong, Zhao Ma, Xin-Yun Huang, Yue-Lan Zou, Xing-Tao Zhou, Xiao-Peng Ma

    Published 2023-12-01
    “…The secondary outcomes include tear meniscus height, the Schirmer I test, corneal and conjunctival sensation, the ocular surface disease index, corneal fluorescein staining, the numerical rating scale and the Chinese DE-related quality of life scale.Ethics and dissemination The trial protocol and informed consent were approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine (identifier: 2021–119), Shanghai Eye Disease Prevention and Treatment Center (identifier: 2022SQ003) and Eye and ENT Hospital of Fudan University (identifier: 2022014).Trial registration number NCT05552820.…”
    Get full text
    Article